c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements

被引:96
|
作者
Suzuki, H
Yagi, K
Kondo, M
Kato, M
Miyazono, K [1 ]
Miyazawa, K
机构
[1] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan
[2] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan
关键词
Ski; Smad; TGF-beta; Smad-binding element;
D O I
10.1038/sj.onc.1207690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-Ski inhibits transforming growth factor-beta (TGF-beta) signaling through interaction with Smad proteins. c-Ski represses Smad-mediated transcriptional activation, probably through its action as a transcriptional co-repressor. c-Ski also inhibits TGF-beta-induced downregulation of genes such as c-myc. How ever, mechanisms for transcriptional regulation of target genes by c-Ski have not been fully determined. In this study, we examined how c-Ski inhibits both TGF-beta-induced transcriptional activation and repression. DNA-affinity precipitation analysis revealed that c-Ski enhances the binding of Smad2 and 4, and to a lesser extent Smad3, to both CAGA and TGF-beta1 inhibitory element probes. A c-Ski mutant, which is unable to interact with Smad4, failed to enhance the binding of Smad complex on these probes and to inhibit the Smad-responsive promoter. These results suggest that stabilization of inactive Smad complexes on DNA is a critical event in c-Ski-mediated inhibition of TGF-beta signaling.
引用
收藏
页码:5068 / 5076
页数:9
相关论文
共 50 条
  • [1] c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements
    Hiroyuki Suzuki
    Ken Yagi
    Miki Kondo
    Mitsuyasu Kato
    Kohei Miyazono
    Keiji Miyazawa
    Oncogene, 2004, 23 : 5068 - 5076
  • [2] Association of high c-SKI/SnoN expression and eficient TGF-β/SMAD signaling in human melanoma cells
    Javelaud, D.
    Alexaki, V.
    van Kempen, L.
    Le Scolan, E.
    Luo, K.
    Mauviel, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S147 - S147
  • [3] Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression
    Delphine Javelaud
    Leon van Kempen
    Vasileia I Alexaki
    Erwan Le Scolan
    Kunxin Luo
    Alain Mauviel
    Molecular Cancer, 10
  • [4] Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression
    Javelaud, Delphine
    van Kempen, Leon
    Alexaki, Vasileia I.
    Le Scolan, Erwan
    Luo, Kunxin
    Mauviel, Alain
    MOLECULAR CANCER, 2011, 10
  • [5] Artesunate inhibits the development of PVR by suppressing the TGF-β/Smad signaling pathway
    Wang, Zi-Yi
    Zhang, Yu
    Chen, Jie
    Wu, Ling-Dan
    Chen, Mei-Ling
    Chen, Ci-Min
    Xu, Qi-Hua
    EXPERIMENTAL EYE RESEARCH, 2021, 213
  • [6] TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
    Yu, Xiao-Yong
    Sun, Qian
    Zhang, Ya-Mei
    Zou, Liang
    Zhao, Ying-Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling
    Jiang, Zhitao
    Cao, Qianyu
    Dai, Guoliang
    Wang, Jianchun
    Liu, Chundi
    Lv, Lingyan
    Pan, Jinhuo
    ONCOTARGETS AND THERAPY, 2019, 12 : 509 - 518
  • [8] c-Ski accelerates renal cancer progression through the attenuation of TGF- β signaling
    Miyakuni, Kosuke
    Taguchi, Luna
    Ehata, Shogo
    Fukayama, Masashi
    Miyazono, Kohei
    CANCER SCIENCE, 2018, 109 : 993 - 993
  • [9] Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes
    Kim, Kyung-Ok
    Sampson, Erik R.
    Maynard, Robert D.
    O'Keefe, Regis J.
    Chen, Di
    Drissi, Hicham
    Rosier, Randy N.
    Hilton, Matthew J.
    Zuscik, Michael J.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (06) : 2156 - 2166
  • [10] Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway
    Yuan, Xingxing
    Gong, Zhiqiang
    Wang, Bingyu
    Guo, Xueying
    Yang, Lei
    Li, Dandan
    Zhang, Yali
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018